Correspondence

Four new appointments to ACMD

Published 5 July 2010

Four new appointments to the Advisory Council on the Misuse of Drugs (ACMD) have been announced today (30 June 2010) by James Brokenshire, minister for crime prevention.

The new appointees are:

  • Dr Roger Brimblecombe, pharmacologist and a former holder of a number of senior positions in the pharmaceutical industry
  • Professor Raymond Hill, neuropharmacologist and a former holder of senior positions in the pharmaceutical industry, current president of the British Pharmacological Society and a member of the Nuffield Council on Bioethics
  • Mr Graham Parsons, pharmacist with special interest (substance misuse), NHS Plymouth
  • Dr Jason Aldiss, veterinary scientist, specialising in public health including veterinary medicines

James Brokenshire said:

I welcome these new members to the Advisory Council on the Misuse of Drugs and look forward to working with them over the forthcoming years. This coalition government recognises the range of expertise in the ACMD and the valuable role it has to play in informing government drug policy.

The 3-year appointments attract no remuneration and have been made in accordance with the code of practice of the Commissioner for Public Appointments (OCPA).

The ACMD was established under the Misuse of Drugs Act 1971. It is the duty of the ACMD to keep drugs misuse, in the United Kingdom, under review and to advise the government on measures for preventing misuse and social problems arising from it.

Professor Les Iversen is interim chair of the ACMD. Members are appointed on an individual basis and not as representatives of the organisations for whom they work.